Price T Rowe Associates Inc Vyne Therapeutics Inc. Transaction History

Price T Rowe Associates Inc

  • $836 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.5 - $1.15 $9,600 - $22,080
-19,200 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$1.39 - $3.47 $28,981 - $72,349
-20,850 Reduced 52.06%
19,200 $27,000
Q2 2021

Aug 16, 2021
BUY
$3.24 - $6.92 $24,653 - $52,654
7,609 Added 23.45%
40,050 $141,000
Q1 2021

May 17, 2021
BUY
$6.34 - $12.68 $205,675 - $411,351
32,441 New
32,441 $222,000

Others Institutions Holding VYNE

# of Institutions
3
Shares Held
36.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $108M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email